Delivery Order SPE2DB22D3301-SPE2DB25FX9JC
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,286.89, is for the delivery of INJECTAFER 750 MG/15 ML VIAL 15ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,518.76 firm fixed-price delivery order is for Injectafer 750 mg/15 ml vials, with a period of performance through November 13, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $12,663.12, is for the delivery of INJECTAFER 750 MG/15 ML VIAL 15ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the provision of INJECTAFER 750 MG/15 ML VIAL 15ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $16,215.55, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB24FHQ03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $44,828.15 and is for the delivery of the pharmaceutical product INJECTAFER 750 MG/15 ML VIAL 15ML. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 6, 2024. This award is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer, a 750 mg/15 mL injectable medication. The $2,414.43 firm fixed-price delivery order has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation. The contract, valued at $34,643.76, is for the delivery of Injectafer 750 mg/15 mL vials. It is a firm fixed-price delivery order contract with an ultimate completion date of August 2, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYREdNdz09) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $9,456.06. The award is for the pharmaceutical product Injectafer (750 mg/15 ml vial, 15 ml), with an ultimate completion date of November 25, 2024. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for the DLA to...
This federal contract award is a delivery order valued at $2,241.90 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for medical products, including "INJECTOR DRG DLV BD PHASEAL IV LL N35 LF", with a completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,469.23, is a delivery order for the injectable medication Injectafer 750 mg/15 ml vial. The contract has a completion date of February 26, 2025 and uses a firm fixed price pricing type. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...